Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01901406
Other study ID # 3-2013-0094
Secondary ID
Status Completed
Phase N/A
First received July 2, 2013
Last updated August 11, 2014
Start date July 2013
Est. completion date June 2014

Study information

Verified date August 2014
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority South Korea: Korea Food and Drug Administration (KFDA)
Study type Observational

Clinical Trial Summary

Epiretinal membrane is common disease, affecting 5~10 % incidence over 60 years old population. It reduce visual acuity, cause metamorphopsia. In the past, vitrectomy and epiretinal membranectomy was indicated in patients with visual acuity less than 20/40, but nowadays with technical improvement and surgical instrument renovation, it seems to have been changed the surgical indication. Therefore, we plan to evaluate the changes of binocular visual acuity, aniseikonia in patients with epiretinal membrane.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date June 2014
Est. primary completion date June 2014
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria:

- Idiopathic epiretinal membrane who had impaired vision or metamorphopsia, want to undergo vitrectomy

- Age more than 20 years and less than 90 years old

Exclusion Criteria:

- secondary epiretinal membrane due to retinal surgery,

- impaired visual acuity less than 20/40 in the normal eye(Snellen chart) due to severe cataract

- glaucoma patients

- complication during vitrectomy (ex. Retinal tear, silicone oil injection, …)

- other retinal disease except epiretinal membrane

- other ocular surgery history within 3 months

- intellectual problems or illiterate whom could not obtained informed consent

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Institute of Vision Research, Department of Ophthalmology, Gangnam Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of Stereopsis tested by TNO test (arc of second) Stereopsis is normal binocular vision. Its presence or absence is an important indicator of the state of binocularity. The TNO test is graded to provide retinal disparities ranging from 15 to 480 second of arc. from Initial screening day before surgey to postoperative 6 months No
Primary Titmus test (arc of second) from Initial screening day before surgey to postoperative 6 months No